We are live on
!
Find out more
BL
BCWM LLC Portfolio holdings
AUM
$353M
1-Year Est. Return
20.1%
This Fund
S&P 500
This Quarter
Est. Return
+1.93%
1 Year Est. Return
+20.1%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$304M
AUM Growth
-$11.8M
(-3.8%)
Cap. Flow
-$16.9M
Cap. Flow
% of AUM
-5.55%
Top 10 Holdings %
Top 10 Hldgs %
33.88%
Holding
63
New
3
Increased
34
Reduced
23
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$5.81M |
| 2 |
US Bancorp
USB
|
+$4.87M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$1.29M |
| 4 |
3M
MMM
|
+$696K |
| 5 |
AT&T
T
|
+$666K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
|
+$6.92M |
| 2 |
Gilead Sciences
GILD
|
+$5.12M |
| 3 |
Walmart Inc
WMT
|
+$4.48M |
| 4 |
D.R. Horton
DHI
|
+$4.03M |
| 5 |
Zimmer Biomet
ZBH
|
+$3.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 11.83% |
| 2 | Technology | 9.95% |
| 3 | Industrials | 9.92% |
| 4 | Materials | 8.89% |
| 5 | Consumer Discretionary | 8.45% |
Similar funds
FWM
MCMU
OBGC
EC
FWC
PIC
ACA
SCA
BCWM LLC's Q2 2023 Portfolio in Review
As of Q2 2023, BCWM LLC held 63 positions worth $304M, down 3.8% from $315M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
BCWM LLC withdrew a net $16.9M in Q2 2023, closing 2 positions and reducing 23 holdings. Its most notable exit was ETF Series Solutions Trust Range Cancer Therapeutics ETF, an estimated $6.92M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 12% of assets, up from 11% a quarter earlier, followed by Technology and Industrials.
Against the trend, BCWM LLC opened a new position in Target worth $5.17M.
- BCWM LLC's largest Q2 2023 buy was Target: 39,166 shares worth $5.17M.
- BCWM LLC added most to 3M in Q2 2023, an estimated $696K increase.
- BCWM LLC's biggest Q2 2023 reduction was Walmart Inc, cutting an estimated $4.48M.
- BCWM LLC fully exited ETF Series Solutions Trust Range Cancer Therapeutics ETF in Q2 2023, selling an estimated $6.92M.
- BCWM LLC's ten largest holdings make up 34% of its $304M portfolio in Q2 2023.
- BCWM LLC opened 3 new positions and closed 2 in Q2 2023.
- BCWM LLC's portfolio value fell 3.8% quarter-over-quarter to $304M.
Based on BCWM LLC's 13F filing for Q2 2023, filed 14 Aug 2023.